Oral administration of the anti-inflammatory substance triflusal results in the downregulation of constitutive transcription factor NF-κB in the postnatal rat brain
- 1 July 2000
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 288 (1) , 41-44
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- STAT3 and NFκB Activation Precedes Glial Reactivity in the Excitotoxically Injured Young Cortex but not in the Corresponding Distal Thalamic NucleiJournal of Neuropathology & Experimental Neurology, 2000
- Evidence for the involvement of TNF and NF-?B in hippocampal synaptic plasticitySynapse, 1999
- Inhibition of NF-κB potentiates amyloid β-mediated neuronal apoptosisProceedings of the National Academy of Sciences, 1999
- 4‐trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2‐hydroxy‐4‐trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor κB activationBritish Journal of Pharmacology, 1999
- Stat3 and NFκB glial expression after excitotoxic damage to the postnatal brainNeuroReport, 1998
- Apoptosis: Activate NF-κB or die?Current Biology, 1997
- Selective Activation of NF-κB by Nerve Growth Factor Through the Neurotrophin Receptor p75Science, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons.Proceedings of the National Academy of Sciences, 1995
- Constitutive NF-kappa B activity in neurons.Molecular and Cellular Biology, 1994